W Peters

872 total citations
42 papers, 675 citations indexed

About

W Peters is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, W Peters has authored 42 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Public Health, Environmental and Occupational Health, 11 papers in Genetics and 8 papers in Pathology and Forensic Medicine. Recurrent topics in W Peters's work include Research on Leishmaniasis Studies (12 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). W Peters is often cited by papers focused on Research on Leishmaniasis Studies (12 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). W Peters collaborates with scholars based in Netherlands, Curacao and Germany. W Peters's co-authors include R. Killick‐Kendrick, L. P. Colly, Roel Willemze, J.W.W. Coebergh, M.L.G. Janssen‐Heijnen, V.E.P.P. Lemmens, D.J. van Spronsen, H. F. L. Guiot, R. Willemze and Sabir Elbihari and has published in prestigious journals such as Nature, Blood and European Journal of Cancer.

In The Last Decade

W Peters

41 papers receiving 646 citations

Peers

Countries citing papers authored by W Peters

Since Specialization

Citations

This map shows the geographic impact of W Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Peters more than expected).

Fields of papers citing papers by W Peters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Peters. The network helps show where W Peters may publish in the future.

Co-authorship network of co-authors of W Peters

This figure shows the co-authorship network connecting the top 25 collaborators of W Peters. A scholar is included among the top collaborators of W Peters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Peters. W Peters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study 2015 ·Quality of Life Research ·(unknown), Martyn Ronald Schaafsma, Peter Joosten, E.F.M. Posthuma, S. Wittebol, Peter C. Huijgens, (unknown), Gerard Vreugdenhil, Hein P. J. Visser, W Peters, Z. Erjavec, P. Wijermans, Simon Daenen, K.G. van der Hem, Marinus H. J. van Oers, Carin A. Uyl‐de Groot	36
2	A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands 2012 ·Haematologica ·Simone Oerlemans, Floortje Mols, Djamila E. Issa, (unknown), W Peters, Marnix L.M. Lybeert, Wobbe P. Zijlstra, J.W.W. Coebergh, Lonneke V. van de Poll‐Franse	70
3	Chronic Lymphocytic Leukaemia in the Netherlands: Trends in incidence, treatment and survival, 1989–2008 2011 ·European Journal of Cancer ·Esther C. van den Broek, Arnon P. Kater, S.A.M. van de Schans, Henrike E. Karim‐Kos, M.L.G. Janssen‐Heijnen, W Peters, Peet Nooijen, J.W.W. Coebergh, E.F.M. Posthuma	25
4	Hepatosplenic γδ T-cell lymphoma: A case report 2007 ·European Journal of Internal Medicine ·Hielke J. Meulenbeld, Wilko Spiering, Peet Nooijen, W Peters, G.J. Creemers	3
5	Independent prognostic effect of co-morbidity in lymphoma patients: Results of the population-based Eindhoven Cancer Registry 2005 ·European Journal of Cancer ·D.J. van Spronsen, M.L.G. Janssen‐Heijnen, V.E.P.P. Lemmens, W Peters, J.W.W. Coebergh	69
6	Compassionate use programme of irinotecan in colorectal cancer patients in The Netherlands. 2003 ·PubMed ·W W ten Bokkel Huinink, C.J. van Groeningen, Emile E. Voest, W Peters, (unknown), (unknown)	3
7	Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884 2001 ·Blood ·(unknown), Berthe M.P. Aleman, M. Henry‐Amar, Umberto Tirelli, Anton Hagenbeek, Patrice Carde, W Peters, Radka Tomšič, A Van Hoof, M. van ‘t Veer, José Thomas, (unknown), Hanneke C. Kluin‐Nelemans, Catherine Sebban, Dominique Bron, Houchingue Eghbali, A. Pinna, (unknown)	6
8	Cutaneous leukocytoclastic vasculitis in relation to streptokinase. 1992 ·PubMed ·(unknown), (unknown), W Peters	0
9	Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia 1991 ·Annals of Hematology ·R. Willemze, Willem E. Fibbe, Hanneke C. Kluin‐Nelemans, (unknown), Dick J. Richel, W Peters, G. J. den Ottolander, Anneke Brand, F. E. Zwaan	12
10	Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin 1990 ·Infection ·H. F. L. Guiot, J.W.M. van der Meer, R. van Furth, W Peters, P.J. van den Broek, R. Willemze, J. A. Kramps	36
11	Cell kinetics after high dose cytosine arabinoside in patients with acute myelocytic leukemia 1990 ·Annals of Hematology ·L. P. Colly, W Peters, (unknown), Roel Willemze	4
12	Hybrid formation within the genus Leishmania? 1989 ·PubMed ·(unknown), (unknown), Sabir Elbihari, (unknown), Smith, W Peters	52
13	Day-6 bone marrow aspirate for the prediction of response to remission induction therapy for acute myelogenous leukaemia 1988 ·Annals of Hematology ·W Peters, R. Willemze, F. E. Zwaan, L. P. Colly	7
14	High-dose cytosine arabinoside: pharmacological and clinical aspects 1988 ·Annals of Hematology ·W Peters, L. P. Colly, Roel Willemze	29
15	Results of induction and consolidation treatment with intermediate and high‐dose cytosine arabinoside and m‐Amsa of patients with poor‐risk acute myelogeneous leukaemia 1988 ·European Journal Of Haematology ·W Peters, Roel Willemze, L. P. Colly	15
16	Short‐term intensive treatment (V.A.A.P.) of adult acute lymphoblastic leukemia and lymphoblastic lymphoma 1988 ·European Journal Of Haematology ·Roel Willemze, W Peters, L. P. Colly	15
17	Fever, lymphadenopathy and shock in a 16-year-old girl. 1988 ·PubMed ·Willem Moolenaar, W Peters, Jenny Bolk	5
18	Leishmania and the macrophage. 1987 ·R. S. Bray, James Alexander, W Peters, R. Killick‐Kendrick	7
19	Current antimalarials and new drug developments 1984 ·Springer eBooks ·W Peters, W. H. G. Richards, R. Baurain	12
20	Liver enlargement and malaria in New Guinea. 1959 ·PubMed ·W Peters	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact